top of page
Executive Spotlights

Atai Life Sciences Announces Leadership Transition

New York and Berlin, May 15, 2024 (Globe Newswire) -- Atai Life Sciences, a clinical-stage biopharmaceutical company, has unveiled its first quarter 2024 financial results and shared corporate updates. Notably, Co-Founder Florian Brand will step down as CEO in a planned transition by the end of 2024. He will be succeeded by Co-Founder and current Chief Scientific Officer, Srinivas Rao, M.D., Ph.D..


Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e

Kommentare


Life Science Headlines
bottom of page